Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia.

Hoffman HJ, LaVerda NL, Young HA, Levine PH, Alexander LM, Brem R, Caicedo L, Eng-Wong J, Frederick W, Funderburk W, Huerta E, Swain S, Patierno SR.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1655-63. doi: 10.1158/1055-9965.EPI-12-0479.

2.

Patient navigation for breast and colorectal cancer in 3 community hospital settings: an economic evaluation.

Donaldson EA, Holtgrave DR, Duffin RA, Feltner F, Funderburk W, Freeman HP.

Cancer. 2012 Oct 1;118(19):4851-9. doi: 10.1002/cncr.27487. Epub 2012 Mar 5.

3.

AHR-6646: a new, long-acting neuroleptic.

Johnson DN, Turley BG, Jones MR, Coffin CB, Leonard CA, Funderburk WH.

Prog Neuropsychopharmacol. 1979;3(5-6):513-20.

PMID:
45570
4.

Assessment of the neuroleptic potential of some novel benzamide, butyrophenone, phenothiazine and indole derivatives.

Costall B, Funderburk WH, Leonard CA, Naylor RJ.

J Pharm Pharmacol. 1978 Dec;30(12):771-8. No abstract available.

PMID:
32242
5.

(1-(3-(Phenothiazin-10-yl)propyl)-4-piperidinyl)phenylmethanones, a novel class of long-acting neuroleptic agents.

Boswell RF Jr, Welstead WJ Jr, Duncan RL Jr, Johnson DN, Funderburk WH.

J Med Chem. 1978 Jan;21(1):136-9.

PMID:
22753
6.

Lack of cytotoxic effect of fenfluramine.

Funderburk WH.

Neurochem Res. 1977 Dec;2(6):723-4. doi: 10.1007/BF00963785. No abstract available.

PMID:
24272331
7.

Preclinical evaluation of AHR-2244 a new psychotherapeutic agent.

Johnson DN, Funderburk WH, Ward JW.

Arch Int Pharmacodyn Ther. 1974 Oct;211(2):326-40. No abstract available.

PMID:
4477709
8.

"In-and-out" surgery using general anesthesia. A personal experience.

Funderburk WW.

J Natl Med Assoc. 1974 Sep;66(5):416-9. No abstract available.

9.

Synthesis of some N-carboxylic acid derivatives of 3-phenoxypyrrolidines, 4-phenoxypiperidines, and 3-phenoxynortropanes with muscle relaxant and anticonvulsant activities.

Boswell RF Jr, Helsley GC, Duncan RL Jr, Funderburk WH, Johnson DN.

J Med Chem. 1974 Sep;17(9):1000-8. No abstract available.

PMID:
4528755
10.

Causes of death soon after injury.

Funderburk WW.

Med Ann Dist Columbia. 1974 Aug;43(8):407-8. No abstract available.

PMID:
4527689
11.

5-(2-Aminoethyl)-2-oxazolidinones with central nervous system depressant and antiinflammatory activity.

Welstead WJ Jr, Helsley GC, Taylor CR, Turnbull LB, DaVanzo JP, Funderburk WH, Alphin RS.

J Med Chem. 1973 Oct;16(10):1129-32. No abstract available.

PMID:
4795993
12.

Contrasting effects of two 5-hydroxytryptamine-depleting drugs on sleep patterns in cats.

Johnson DN, Funderburk WH, Ruckart RT, Ward JW.

Eur J Pharmacol. 1972 Oct;20(1):80-4. No abstract available.

PMID:
4264267
13.

Breast lesions in blacks.

Funderburk WW, Rosero E, Leffall LD.

Surg Gynecol Obstet. 1972 Jul;135(1):58-60. No abstract available.

PMID:
4338145
14.

A modification of the Whitehead hemorrhoidectomy.

White JE, Syphax B, Funderburk WW.

Surg Gynecol Obstet. 1972 Jan;134(1):103-5. No abstract available.

PMID:
4550144
15.

Neuropharmacologic analysis of AHR-2277 a new psychotherapeutic agent.

Johnson DN, Funderburk WH, Ward JW.

Arch Int Pharmacodyn Ther. 1971 Nov;194(1):197-208. No abstract available.

PMID:
5123867
16.

Species-dependent effects of fenfluramine on the central nervous system.

Funderburk WH, Hash AM Jr, Hazelwood JC, Ward JW.

J Pharm Pharmacol. 1971 Jul;23(7):509-13. No abstract available.

PMID:
4397450
17.

Comparative effects of ten anorectic drugs on sleep-wakefulness patterns in cats.

Johnson DN, Funderburk WH, Ward JW.

Eur J Pharmacol. 1971 Jul;15(2):176-9. No abstract available.

PMID:
4341650
18.

Is 5-hydroxytryptamine involved in the mechanism of action of fenfluramine?

Funderburk WH, Hazelwood JC, Ruckart RT, Ward JW.

J Pharm Pharmacol. 1971 Jun;23(6):468-70. No abstract available.

PMID:
4397197
19.

Effects of fenfluramine on sleep-wakefulness in cats.

Johnson DN, Funderburk WH, Ward JW.

Psychopharmacologia. 1971;20(1):1-9. No abstract available.

PMID:
5565743
20.

Cortical stimulation in rabbits by fenfluramine is probably due to an unusual metabolite.

Funderburk WH, Ward JW.

J Pharm Pharmacol. 1970 Oct;22(10):786-7. No abstract available.

PMID:
4394790
21.

Preclinical evaluation of AHR-1118, a potential antidepressant drug.

Johnson DN, Funderburk WH, Ward JW.

Curr Ther Res Clin Exp. 1970 Jun;12(6):402-13. No abstract available.

PMID:
4987348
22.

Aroylpiperidines and pyrrolidines. A new class of potent central nervous system depressants.

Duncan RL Jr, Helsley GC, Welstead WJ Jr, DaVanzo JP, Funderburk WH, Lunsford CD.

J Med Chem. 1970 Jan;13(1):1-6. No abstract available.

PMID:
5460893
23.

Effects of psychotherapeutic drugs on hypothalamic- induced hissing in cats.

Funderburk WH, Foxwell MH, Hakala MW.

Neuropharmacology. 1970 Jan;9(1):1-7. No abstract available.

PMID:
5426755
24.

Evaluation of nipple discharge in benign and malignant diseases.

Funderburk WW, Syphax B.

Cancer. 1969 Dec;24(6):1290-6. No abstract available.

PMID:
5353974
25.

Muscle relaxant and anticonvulsant properties of some 1-carbamoyl-3-aroxylpyrrolidines and 1-carbamoyl-4-aroylpiperidines.

Helsley GC, Duncan RL Jr, Funderburk WH, Johnson DN.

J Med Chem. 1969 Nov;12(6):1098-100. No abstract available.

PMID:
5351456
26.

Synthesis and analgetic activity of some 1-substituted 3-pyrrolidinylanilides and dihydrobenzoxazinones.

Helsley GC, Lunsford CD, Welstead WJ Jr, Boswell RF Jr, Funderburk WH, Johnson DN.

J Med Chem. 1969 Jul;12(4):583-6. No abstract available.

PMID:
5793145
27.

Analgetic activity of alpha-1-(1-methyl-3-pyrrolidinyl)-1-phenylpropyl propionate fumarate (AHR-1767).

Funderburk WH, Foxwell MH, Johnson DN, Ward JW.

Arch Int Pharmacodyn Ther. 1969 Apr;178(2):446-56. No abstract available.

PMID:
5355570
28.

Studies on the site of action of a new anorectic agent, fenfluramine.

Foxwell MH, Funderburk WH, Ward JW.

J Pharmacol Exp Ther. 1969 Jan;165(1):60-70. No abstract available.

PMID:
5782834
29.

Inhibition of release of slow-reacting substance by arsenic.

Funderburk WH, Foxwell M, Ward JW.

Eur J Pharmacol. 1969 Jan;5(2):203-8. No abstract available.

PMID:
4181157
30.

A volunteer physician's experience in South Vietnam.

Funderburk WW.

J Natl Med Assoc. 1968 Sep;60(5):435-9. No abstract available.

31.

Analgetics. Esters of 3-pyrrolidinemethanols.

Helsley GC, Richman JA, Lunsford CD, Jenkins H, Mays RP, Funderburk WH, Johnson DN.

J Med Chem. 1968 May;11(3):472-5. No abstract available.

PMID:
5656485
32.

Electrophysiologic analysis of the site of action of doxapram hydrochloride.

Funderburk WH, Oliver KL, Ward JW.

J Pharmacol Exp Ther. 1966 Mar;151(3):360-8. No abstract available.

PMID:
4380045
33.

Possible role of hyperventilation in the CNS effects attributed to tubocurarine.

Oliver KL, Funderburk WH.

Electroencephalogr Clin Neurophysiol. 1965 Nov;19(5):501-8. No abstract available.

PMID:
4158661
34.

CONTRAST MAMMOGRAPHY IN BREAST DISCHARGE.

FUNDERBURK WW, SYPHAX B, SMITH CW.

Surg Gynecol Obstet. 1964 Aug;119:276-80. No abstract available.

PMID:
14200957
35.
36.

SOFT-TISSUE MAMMOGRAPHY WITH COMMENTS ON A SURVEY.

FUNDERBURK WW, PRESS HC, DAVIS TW.

Med Ann Dist Columbia. 1963 Nov;32:447-50 PASSIM. No abstract available.

PMID:
14078145
37.

PREPARATION AND ANTICONVULSANT ACTIVITY OF N-SUBSTITUTED BENZENEDISULFONAMIDES.

HOLLAND GF, FUNDERBURK WH, FINGER KF.

J Med Chem. 1963 May;6:307-12. No abstract available.

PMID:
14185991
38.

Spontaneous rupture of the small bowel in adults. Report of two unusual cases.

FUNDERBURK WW, WHITE JE.

J Natl Med Assoc. 1962 May;54:337-43. No abstract available.

39.

Some effects of sodium gamma-hydroxybutyrate on the central nervous system.

DRAKONTIDES AB, SCHNEIDER JA, FUNDERBURK WH.

J Pharmacol Exp Ther. 1962 Mar;135:275-84. No abstract available.

PMID:
13887725
40.

EEG and biochemical findings with MAO inhibitors.

FUNDERBURK WH, FINGER KF, DRAKONTIDES AB, SCHNEIDER JA.

Ann N Y Acad Sci. 1962 Jan 13;96:289-302. No abstract available.

PMID:
13895911
41.

Survivals following reoperation for cancer of the stomach.

FUNDERBURK WW.

J Natl Med Assoc. 1962 Jan;54:80-6. No abstract available.

42.

Anticonvulsant effect of nialamide and diphenylhydantoin.

P'AN SY, FUNDERBURK WH, FINGER KF.

Proc Soc Exp Biol Med. 1961 Dec;108:680-3. No abstract available.

PMID:
14482985
43.

Drug therapy.

WILCOX KW, FUNDERBURK WH, WILCOX PH.

Prog Neurol Psychiatry. 1957;12:595-624. No abstract available.

PMID:
13494576
44.

Improving senile behavior with reserpine and ritalin; new approach with use of methyl phenylpiperidylacetate.

FERGUSON JT, FUNDERBURK WH.

J Am Med Assoc. 1956 Jan 28;160(4):259-63. No abstract available.

PMID:
13278184
45.

Drug therapy; physiodynamic therapy. II.

FUNDERBURK WH, WILCOX KW, WILCOX PH.

Prog Neurol Psychiatry. 1956;11:425-56. No abstract available.

PMID:
13370660
46.

Physiodynamic therapy (shock and drug therapies).

WILCOX PH, FUNDERBURK WH, WILCOX KW.

Prog Neurol Psychiatry. 1955;10:567-608. No abstract available.

PMID:
13266897
47.

Some effects of N-methyl-alpha-phenyl-succinimide (milontin) on the central nervous system.

FUNDERBURK WH, WOODCOCK RT.

J Pharmacol Exp Ther. 1954 Dec;112(4):404-12. No abstract available.

PMID:
13222234
48.

Pharmacological properties of benzazoles. III. Effect of 2-aminobenzothiazoles on the electroencephalogram.

FUNDERBURK WH, KING EE, UNNA KR.

J Pharmacol Exp Ther. 1953 May;108(1):94-103. No abstract available.

PMID:
13053427
49.

Pharmacological properties of benzazoles. II. Sites of action in the central nervous system.

FUNDERBURK WH, KING EE, DOMINO EF, UNNA KR.

J Pharmacol Exp Ther. 1953 Mar;107(3):356-67. No abstract available.

PMID:
13035674
50.

Site of action of 2, 2-diethyl-1,3-propanediol (prenderol) on the central nervous system.

FUNDERBURK WH, UNNA KR.

J Pharmacol Exp Ther. 1953 Mar;107(3):344-55. No abstract available.

PMID:
13035673

Supplemental Content

Loading ...
Support Center